0 NASDAQ Companies - April 10, 2024Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in […]Read More
0 NASDAQ Companies - April 10, 2024AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024WEST PALM BEACH, Fla., April 10, 2024 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it […]Read More
0 TSX Venture News - April 10, 2024BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor ConferenceMISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will […]Read More
0 NYSE Companies - April 10, 2024AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian CancerOCALA, Fla., April 10, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced top-line interim data indicating […]Read More
0 NASDAQ Companies - April 10, 2024Blue Foundry Bancorp Schedules First Quarter 2024 Earnings Conference CallRUTHERFORD, N.J., April 10, 2024 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue […]Read More
0 NASDAQ Companies - April 10, 2024Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™– PALI-2108 in development for the treatment of moderate-to-severe ulcerative colitis (UC) advancing towards Phase 1 clinical study before year […]Read More
0 NASDAQ Companies - April 10, 2024Navient to announce first quarter 2024 results, host earnings webcast April 24HERNDON, Va., April 10, 2024 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing […]Read More
0 NASDAQ Companies - April 10, 2024Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease TherapeuticSPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) — Silo Pharma, […]Read More
0 NYSE Companies - April 10, 2024Vishay Precision Group Announces Date for Its First Quarter Fiscal 2024 Earnings Conference CallMALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and […]Read More
0 NASDAQ Companies - April 10, 2024MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing […]Read More